Transendocardial injection of expanded autologous CD34+ cells after myocardial infarction: Design of the EXCELLENT trial.

Roncalli J, Roubille F, Meyer N, Pompilio G, Leroux L, Henon P, Trebuchet G, Criquet A, de Kalbermatten M, Saloux E, Manrique A, Marie PY, Bhatt DL, Solomon SD, Montalescot G, Newby DE, Zannad F, EXCELLENT Trial Investigators

Open source

DOI: 10.1002/ehf2.15124
Published: 2025 Apr
Container: ESC heart failure
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1002/ehf2.15124,
  title = {Transendocardial injection of expanded autologous CD34+ cells after myocardial infarction: Design of the EXCELLENT trial.},
  author = {Roncalli J and Roubille F and Meyer N and Pompilio G and Leroux L and Henon P and Trebuchet G and Criquet A and de Kalbermatten M and Saloux E and Manrique A and Marie PY and Bhatt DL and Solomon SD and Montalescot G and Newby DE and Zannad F and EXCELLENT Trial Investigators},
  year = {2025},
  journal = {ESC heart failure},
  doi = {10.1002/ehf2.15124},
  url = {https://doi.org/10.1002/ehf2.15124}
}

RIS

TY  - JOUR
TI  - Transendocardial injection of expanded autologous CD34+ cells after myocardial infarction: Design of the EXCELLENT trial.
AU  - Roncalli J
AU  - Roubille F
AU  - Meyer N
AU  - Pompilio G
AU  - Leroux L
AU  - Henon P
AU  - Trebuchet G
AU  - Criquet A
AU  - de Kalbermatten M
AU  - Saloux E
AU  - Manrique A
AU  - Marie PY
AU  - Bhatt DL
AU  - Solomon SD
AU  - Montalescot G
AU  - Newby DE
AU  - Zannad F
AU  - EXCELLENT Trial Investigators
PY  - 2025
JO  - ESC heart failure
DO  - 10.1002/ehf2.15124
UR  - https://doi.org/10.1002/ehf2.15124
ER  -

APA

J, R., F, R., N, M., G, P., L, L., P, H., G, T., A, C., M, D. K., E, S., A, M., PY, M., DL, B., SD, S., G, M., DE, N., F, Z., & Investigators, E. T. (2025). Transendocardial injection of expanded autologous CD34+ cells after myocardial infarction: Design of the EXCELLENT trial.. ESC heart failure. https://doi.org/10.1002/ehf2.15124

Source records

pubmed · retrieved 2026-09-27T09:46:42.209Z